drugset / Trial / NCT01607762

A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics

NCT01607762

Phase 1 Completed 31 enrolled Janssen Research & Development, LLC
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to compare capillary (the smallest of a body's blood vessels) and venous whole blood and plasma concentrations of 5 antipsychotics after given of a single oral, immediate-release dose to healthy participants.

Timeline

Start
2012-02
Primary completion
2012-04
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 5 mg Oral
Subject Olanzapine Small molecule 5 mg Oral
Subject Paliperidone Unknown 3 mg Oral
Subject Quetiapine Small molecule 100 mg Oral
Subject Risperidone Other / unclassified 1 mg Oral

Indications

No indication recorded.